Pharmaceutical microbiology.
2 likes808 views
The document outlines the schedule and details for the 5th annual Pharmaceutical Microbiology Conference held on January 20-21, 2016, in London, UK, featuring workshops focused on microbial contamination control and endotoxin testing. Key speakers and workshops are highlighted, along with the benefits of attending, including insights into contamination control strategies and novel testing methods. Registration information, including early bird pricing and contact details for inquiries, is also provided.
Pharmaceutical microbiology.
- 1. WORKSHOP A Spectrometric and Optical Technologies for Microbial Contamination Control Leader: Andrew Bartko, Research Leader, Battelle 8.30 am - 12.20pm WORKSHOP B Endotoxin Testing: Hot Topics and New Methods in the European Pharmacopoeia Leader: Karolina Heed, Director, Marketing and Sales, Hyglos GmbH 1.00 pm - 4.40pm SMi Presents the 5th Annual Conference on... 20 - 21 JAN 2016Holiday Inn Kensington Forum, London, UK Pharmaceutical Microbiology PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS Tuesday 19th January 2016, Holiday Inn Kensington Forum, London, UK Chairs for 2016: • Oliver Chancel, Sterility and Aseptic Process Assurance Expert, Merial Sas • Francesco Boschi, Microbiological Services Manager, GSK Manufacturing S.p.A • Salomé Gião, Research Scientist, Dyson Technology Ltd Key Speakers for 2016: • Thierry Bonnevay, Microbiology Platform Head QC Development, Sanofi Pasteur • Adrianne Klijn, Group Leader Microbiological and Molecular Analytics, Nestle Research Center • Sabina Lancaster, Senior Manager, Sterility Assurance, Global, QA, GSK • James Drinkwater, Chairman, PHSS • Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca Benefits of attending in 2016: • Gain an in-depth insight into endotoxin testing, validation and LER • Understand the threats posed by VBNCs and how to detect them • Hear specialist advice on contamination control and risk management to minimise costs and maximise efficiency • Gain an international perspective with case studies from across the UK, EU, and USA @SMIPHARM Pioneering new techniques for the prevention detection and management of microorganisms Sponsored by Book by 30th September 2015 to save £400 Book by 30th October 2015 to save £200 Book by 30th November 2015 to save £100 “Real life experience” MedImmune “Interesting with real case study”Merck Serono RBM To attend, contact Matthew Apps on Tel +44 (0) 20 7827 6193, Fax +44 (0) 20 7827 6194, email [email protected] or visit www.smi-online.co.uk/ts07.asp to register online GROUP DISCOUNTS AVAILABLE
- 2. Pharmaceutical Microbiology Day One | Wednesday 20th January 2016 8.30 Registration & Coffee 9.00 Chair's Opening Remarks Oliver Chancel, Sterility and Aseptic Process Assurance Expert, Merial Sas New Mechanisms for Detection and Quality Control 9.10 Particle deposition monitoring the missing link in contamination control • Product contamination • Air and surface cleanliness • Particle deposition • Real time particle deposition measurement Koos Agricola, Contamination Control Specialist, International Confederation of Contamination Control Societies 9.50 Use of RMM in bacteriology lab: Application and implementation • Quantitative bioburden by Chemscan • Rapid sterility testing by rapid milliflex • Detection of mycoplasma by PCR+microarray Thierry Bonnevay, Microbiology Platform Head QC Development, Sanofi Pasteur 10.30 Morning Coffee 11.00 Advanced light microscopy to detect VBNC pathogens and biofilms • Advantages of EDIC microscopy • Providing a rapid, real time analysis of biofilms on opaque, curved, natural or man-made surfaces • Utilising a toolbox of physiological detection techniques to assess viability • Visualising VBNC pathogens and biofilms in situ Bill Keevil, Scientific Advisor to the House of Commons Select Committee on Science & Technology, Head of the Microbiology Group and Director of the Environmental Healthcare Unit. University of Southampton, UK, University of Southampton 11.40 DNA-sequencing based methods: How will they shape of routine microbial testing in the future? • Learn about new mechanisms of bacterial detection using sequencing mechanisms • Gain an insight into rapid microbiology sequencing methods Adrianne Klijn, Group Leader Microbiological and Molecular Analytics, Nestle Research Center 12.20 Networking Lunch Register online at: www.pharma-microbiology.com • Alternatively fa Sponsored by 1.50 Operating a bioburden control facility within the vaccine industry • Bioburen control strategy following recent updates to vaccine regulations • Case study of how the bioburden control strategy can be applied • Calculating bioburden limits and understanding the risk to a bioburden control process. Sabina Lancaster, Senior Manager, Sterility Assurance Global QA, GSK Contamination and Endotoxins 2.30 Endotoxin testing of biologics – new insights • Regulatory requirements, hold-time studies • New endotoxin test procedures for in-process control and product release • Influence of major formulation components on endotoxin detectability • Theory of endotoxin masking (Low Endotoxin Recovery, LER) and recovering masked endotoxin - Case studies Holger Grallert, Vice President, Hyglos GmbH 3.10 Afternoon Tea 3.40 Endotoxin test concerns of biologics • Risk – historical and modern • Emerging perspective on pyrogenicity vs. immunogenicity • Issues • LPS: Levels – Types – Treatments • Dosing and Co-Administration of Non-Biologics Kevin Williams, Senior Scientist, Lonza QC Testing Solutions 4.20 Cleanrooms to clinic – managing microbiology of stem cell manufacture • Background to the stem cell manufacture process (case study) • Microbial test considerations during the manufacture of stem cell therapeutics • Managing the risk of out of specification results Thomas Caws, QC Associate, ReNeuron Group plc 5.00 Chairman's Closing Remarks and Close of Day One Hyglos is dedicated to innovation in Endotoxin Detection & Endotoxin Removal. Based on recombinant reagents, our methods are entirely animal-free without using Horseshoe crabs. The results generated with EndoLISA®, EndoZyme® and Endo-RS® convince customers from biopharmaceutical research and industry, overcoming limitations of currently used methods, including Low Endotoxin Recovery (LER). www.hyglos.com Lonza QC Testing Solutions: Lonza supports the critical needs of your QC laboratory by supplying endotoxin detection reagents, equipment, consumables, in addition to the WinKQCL™ Endotoxin Detection and Analysis Software. Complementary to the endotoxin detection portfolio, Lonza offers MODA™, a robust informatics platform enabling paperless QC processes for environmental monitoring, product testing, and trending. www.lonza.com/lal Merck Millipore - a division of Merck KGaA- is a leading supplier to the global life science industry, offering a broad range of innovative products and services used in the research, development and production of biotech and pharmaceutical drugs through its three business units. www.merckmillipore.com
- 3. Pharmaceutical Microbiology Day Two | Thursday 21st January 2016 Case Studies in Pharmaceutical Microbiology 8.30 Registration & Coffee 9.00 Chairman's Opening Remarks Francesco Boschi, Microbiological Services Manager, GSK Manufacturing S.p.A. 9.10 Sterility case studies and management perspectives • Learn about case studies provided on specific sites • Sharing experience on personal site visits and remarks on issues • How to prevent contamination events • The importance of correct training and management Olivier Chancel, Sterility and Aseptic Process Assurance Expert, Merial Sas 9.50 Risked-based contamination control and environmental monitoring in sterile product manufacturing • Control strategies for sterile product manufacturing; expected new requirement for EU GMP Annex 1 • Best practice in contamination control for Aseptic processing of different product types • Risk based environmental monitoring of manufacturing environments James Drinkwater, Chairman of PHSS Pharmaceutical & Healthcare Sciences Society, PHSS 10.30 Morning Coffee 11.00 Assessment methods for accurate determination of microbial contamination during clean room manufacture • Microbial contamination in the cleanroom • Quantification of risk by airborne deposition • Quantification of risk by surface contact and liquids Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca 11.40 Current practices in disinfectant validation and starting up a cleanroom after a worst case event • Best practice for cleaning and disinfection of cleanroom operations • Elements of disinfectant validation will be covered including coupon studies • Starting up a new cleanroom operation and how to address cleanroom excursions will be covered Jim Polarine, Technical Service Manager, STERIS Corporation 12.20 Networking Lunch 1.40 Afternoon Chair Opening Remarks Salome Giao, Reseach Scientist, Dyson Technology Ltd Sterility VBNCs and Biofilms 1.50 Bioburden test of bulk solutions before sterilising filtration: Current practices and expectations • Scope and limitations of bioburden test on bulk solutions before sterilisation • Regulatory Documents and Guidelines on bioburden • Bioburden test by “conventional” microbiological methods: key issues to obtain reliable and significant • Microbial identifications from bioburden test samples and evaluation of the recovered flora • Bioburden test by Rapid Microbiological Methods Francesco Boschi, Microbiological Services Manager, GSK Manufacturing S.p.A. 2.30 Risk analysis and mitigation of the analysis process of sterility testing in an isolator environment • False positive” sterility tests are a major concern for business continuity • A non-zero percentage Sterility test failure rate is a Regulatory Auditor topic which can be avoided • How to use FMEA as a tool to reduce risk of “false positives”implmentation of risk mitigation and it’s influence on sterility test failure rate Hans Noordergraaf, Microbiologist, Abbott Biologicals B.V. 3.10 Afternoon Tea 3.40 Controlling and monitoring contamination in water for pharmaceutical use (WPU) • Reflecting on how to avoid any contamination of your installation by a bio burden • Explaining the regulatory framework exists and is increasingly demanding as WPU can come into direct or indirect contact with the drug administered to the patient • Water contamination case studies and monitoring Robert Neri, Water for Pharmaceutical Use Referent, Sanofi Pharma 4.20 The viable but non-cultivable (VBNC) state of pathogens: A myth or reality? • VBNC as a controversial and ignored state • Why do cells undergo VBNC? • Are VBNC virulent? • New methods to detect VBNC cells: an urgent need Salome Giao, Reseach scientist, Dyson Technology Ltd 5.00 Chairman's Closing Remarks and Close of Day Two Want to know how you can get involved? Interested in promoting your services to this market? Contact Anna Serazetdinova, SMi Marketing on +44 (0) 207 827 6180, or email: [email protected] ax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711 Supported by SPONSORSHIP AND EXHIBITION OPPORTUNITIES SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to complement your company’s marketing strategy. Prime networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conferences please call: Alia Malick on +44 (0) 20 7827 6168 or email: [email protected]
- 4. HALF-DAY PRE-CONFERENCE WORKSHOP A Tuesday 19th January 2016 9.15am - 12.20 pm Holiday Inn Kensington Forum, Central London, UK Spectrometric and Optical Technologies for Microbial Contamination Control Leader: Andrew Bartko, Research Leader, Battelle Overview of workshop: The workshop will begin with a review the scientific foundation of spectrometric and optical methods that are used for sensing microbes. Fundamental principles will be discussed and related to microbial attributes being interrogated. The Pros and Cons of the methods will be discussed with respect to traditional microbial quality control methods. Finally, the practical aspects of implementation, validation, and regulatory considerations will be discussed. Why should delegates attend this workshop: • Synopsis of Rapid Microbial Methods options to the industry • Technical description of optical sensing of biological materials • Advantages and limitations of contamination sensing • Barriers to implementation • Comparison to traditional methods 8.30 Registration and coffee 9.00 Opening remarks and introductions 9.15 Session 1 - Sensing Fundamentals • Optical and mass spectrometry • Fluorescence, Vibrational, Absorption and Raman Spectroscopy • Mass spectrometry 10.00 Coffee 10.15 Session 2 - Utilization of Spectrometric Methods in Pharmaceutical Production • Advantages and Limitations of New Methods • Comparisons to Traditional Microbial Quality Control 11.00 Coffee 11.15 Session 3 - Implementation • Pitfalls when Implementing Rapid Methods • Regulatory Considerations 12.20 End of Workshop About workshop leader: Dr. Andrew Bartko received a B.S. from the University of Pittsburgh in 1997 and a Ph.D. in physical chemistry in 2002. His graduate work consisted of deciphering spatially heterogeneous relaxation dynamics of glass forming systems using novel rotational single molecule microscopy techniques. In 2002, Dr. Bartko joined the Softmatter Nanotechnology and Advanced Spectroscopy Team at Los Alamos National Laboratory where he studied the ultrafast photophysics of semiconducting quantum dots. Dr. Bartko is a senior scientist in Battelle’s Technology Development Group where he contributes to several applied spectroscopy efforts that focus on biological and chemical sensing. Dr. Bartko is the manager and technical leader of an interdisciplinary team that is developing Battelle’s Resource Effective Bioidentification System (REBS). Rapid microbial sensing capabilities of REBS have been shown to have practical and strategic importance where rapid, accurate and precise microbial contamination control is required. Dr. Bartko has developed several rapid microbial control applications for industries such as defense, security and industrial market sectors. About the organisation: Every day, around the world, the people of Battelle work at the forefront of scientific innovation to solve what matters most for our government and commercial clients. We create new products, new processes, new technologies - even new industries. We take breakthrough research from theory to market-ready products and services that save lives, meet growing energy demands, protect the environment, and create competitive advantage. We reach into the future for discoveries that improve the quality of life for millions here and now. Battelle is making the world healthier by solving critical challenges in public health, improving the performance of medical devices and helping pharmaceutical companies get new therapies to market quickly and safely. We work with government and commercial clients to condense development timelines and to accelerate innovation in health and life sciences.
- 5. HALF-DAY PRE-CONFERENCE WORKSHOP B Tuesday 19th January 2016 1.00pm - 4.40pm Holiday Inn Kensington Forum, Central London, UK Endotoxin Testing: Hot Topics and New Methods in the European Pharmacopoeia Leaders: Karolina Hedd, Director Marketing & Sales, Hyglos GmbH Holger Grallert, Head of R&D, Hyglos GmbH Overview of workshop: This workshop will provide the fundamental knowledge on the latest technological and regulatory developments regarding the analysis of endotoxin in pharmaceutical products and pharma production environments. Furthermore the underlying mechanisms of Endotoxin Masking (Low Endotoxin Recovery, LER) in pharmaceutical formulations will be explained as well as the newly developed sample preparation methods. Why should delegates attend this workshop: • Quality Control and Production professionals from pharmaceutical and biotech industries • R&D pharma and biotech, especially new drug formulation development • Research Institutes and Universities Programme 1.00 Registration and Refreshments 1.30 Session 1 The recombinant factor C (rFC) test – new method in the European pharmacopoeia •Introduction BET and Pyrogen Test Methods •New Ph. Eur. chapter 5.1.10 2.10 Session 2 Implementation of the rFC test in a routine service laboratory •Endotoxin testing under GMP •Bioanalytical Method Validation of the rFC test 2.50 Afternoon Tea 3.20 Session 3 Endotoxin Detection of Biologics I – What are Masking Effects? •Endotoxin structure and activity •Impact on detection systems •Masking of endotoxin (LER) 4.00 Session 4 Endotoxin Detection of Biologics II – Demasking Endotoxin with dedicated sample preparation •Demasking protocol development •Implementation of demasking method - case studies •Regulatory requirements 4.40 Closing Remarks About the workshop leader: Karolina Heed studied chemistry and economics in Gothenburg Sweden and Florence Italy. Prior to heading the marketing & sales of Hyglos GmbH, Ms. Heed worked almost 10 years in the biotech industry in different roles. About the organisation: Hyglos GmbH is a leading biotech company offering highly innovative technology for removal and detection of Endotoxins, located in Biotechnology Center Bernried, Munich area, Germany. Being an IAFP Safety Innovation Awardee we apply our proprietary technology for developing highly specific bacteriophage-derived proteins for improved detection and removal of harmful bacteria and bacterial toxins such as Lipopolysaccharides (LPS). Hyglos was founded in 2009 and fulfils all development and production requirements according to ISO 9001 and 13485.
- 6. PHARMACEUTICAL MICROBIOLOGY Conference: Wednesday 20th & Thursday 21st January 2016, Holiday Inn Kensington Forum, London, UK Workshops: Tuesday 19th January 2016, Holiday Inn Kensington Forum, London, UK 4 WAYS TO REGISTER If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email [email protected] Payment: If payment is not made at the time of booking, then an invoice will be issued and must be paid immediately and prior to the start of the event. If payment has not been received then credit card details will be requested and payment taken before entry to the event. Bookings within 7 days ofeventrequirepaymentonbooking.AccesstotheDocumentPortalwillnotbegivenuntilpayment has been received. Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another delegate to take your place at any time prior to the start of the event. Two or more delegates may not ‘share’ a place at an event. Please make separate bookings for each delegate. Cancellation: If you wish to cancel your attendance at an event and you are unable to send a substitute, then we will refund/credit 50% of the due fee less a £50 administration charge, providing that cancellation is made in writing and received at least 28 days prior to the start of the event. Regretfullycancellationafterthistimecannotbeaccepted.Wewillhoweverprovidetheconferences documentation via the Document Portal to any delegate who has paid but is unable to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to provide documentation in these circumstances. We cannot accept cancellations of orders placed for Documentation or the Document Portal as these are reproduced specifically to order. If we have to canceltheeventforanyreason,thenwewillmakeafullrefundimmediately,butdisclaimanyfurther liability. Alterations: It may become necessary for us to make alterations to the content, speakers, timing, venue or date of the event compared to the advertised programme. Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about other products and services. Unless you tick here □ we may also share your data with third parties offering complementaryproductsorservices.Ifyouhaveanyqueriesorwanttoupdateanyofthedatathat we hold then please contact our Database Manager [email protected] or visit our website www.smi-online.co.uk/updates quoting the URN as detailed above your address on the attached letter. Unique Reference Number Our Reference LVP-157 Terms and Conditions of Booking DELEGATE DETAILS Please complete fully and clearly in capital letters. Please photocopy for additional delegates. Title: Forename: Surname: Job Title: Department/Division: Company/Organisation: Email: Company VAT Number: Address: Town/City: Post/Zip Code: Country: Direct Tel: Direct Fax: Mobile: Switchboard: Signature: Date: I agree to be bound by SMi's Terms and Conditions of Booking. ACCOUNTS DEPT Title: Forename: Surname: Email: Address (if different from above): Town/City: Post/Zip Code: Country: Direct Tel: Direct Fax: VENUE Holiday Inn Kensington Forum, 97 Cromwell Road, London SW7 4DN, UK □ Please contact me to book my hotel Alternatively call us on +44 (0) 870 9090 711, email: [email protected] or fax +44 (0) 870 9090 712 □ Book by 30th September 2015 to receive £400 off the conference price □ Book by 30th October 2015 to receive £200 off the conference price □ Book by 30th November 2015 to receive £100 off the conference price EARLY BIRD DISCOUNT Payment must be made to SMi Group Ltd, and received before the event, by one of the following methods quoting reference P-157 and the delegate’s name. Bookings made within 7 days of the event require payment on booking, methods of payment are below. Please indicate method of payment: □ UK BACS Sort Code 300009, Account 00936418 □ Wire Transfer Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU Swift (BIC): LOYDGB21013, Account 00936418 IBAN GB48 LOYD 3000 0900 9364 18 □ Cheque We can only accept Sterling cheques drawn on a UK bank. □ Credit Card □ Visa □ MasterCard □ American Express All credit card payments will be subject to standard credit card charges. Card No: □□□□ □□□□ □□□□ □□□□ Valid From □□/□□ Expiry Date □□/□□ CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card Cardholder’s Name: Signature: Date: I agree to be bound by SMi's Terms and Conditions of Booking. Card Billing Address (If different from above): DOCUMENTATION I cannot attend but would like to purchase access to the following Document Portal/paper copy documentation Price Total □ Access to the conference documentation on the Document Portal £499.00 + VAT £598.80 □ The Conference Presentations – paper copy £499.00 - £499.00 (or only £300 if ordered with the Document Portal) PAYMENT VAT VAT at 20% is charged on the attendance fees for all delegates. VAT is also charged on Document portal and literature distribution for all UK customers and for those EU Customers not supplying a registration number for their own country here. ____________________________________________________________________________________________ CONFERENCE PRICES I would like to attend: (Please tick as appropriate) Fee Total □ Conference & 2 Workshops £2697.00 + VAT £3236.40 □ Conference & 1 Workshop AM □ PM □ £2098.00 + VAT £2517.60 □ Conference only £1499.00 + VAT £1798.80 □ 1 Workshop only AM □ PM □ £599.00 + VAT £718.80 □ 2 Workshops £1198.00 + VAT £1437.60 PROMOTIONAL LITERATURE DISTRIBUTION □ Distribution of your company’s promotional literature to all conference attendees £999.00 + VAT £1198.80 The conference fee includes refreshments, lunch, conference papers, and access to the Document Portal. Presentations that are available for download will be subject to distribution rights by speakers. Please note that some presentations may not be available for download. Access information for the document portal will be sent to the e-mail address provided during registration. Details are sent within 24 hours post conference. ONLINE at www.smi-online.co.uk/ts07.asp FAX your booking form to +44 (0) 20 7827 6194 PHONE on +44 (0) 20 7827 6193 POST your booking form to: Matthew Apps, SMi Group Ltd, 2nd Floor South, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS